| |
| |
|
| Insider
Information: |
Dansey Roger D |
| Relationship: |
Director |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
6,749 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,898 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,749 |
|
|
| Total
Value |
$3,898 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -29.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2018-06-15 |
0 |
Premium* |
|
|
Inovio Biomedical Corp |
INO |
Director |
2024-05-15 |
6,749 |
2022-05-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-09-21 |
4 |
AS |
$206.50 |
$14,662 |
D/D |
(71) |
116,677 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2021-12-20 |
4 |
AS |
$149.85 |
$41,958 |
D/D |
(280) |
88,641 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2021-12-21 |
4 |
AS |
$155.58 |
$43,562 |
D/D |
(280) |
88,361 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-04-06 |
4 |
AS |
$205.86 |
$68,550 |
D/D |
(333) |
99,389 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
AS |
$116.33 |
$40,716 |
D/D |
(350) |
107,659 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2020-08-17 |
4 |
AS |
$157.79 |
$71,006 |
D/D |
(450) |
122,493 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
609 |
99,722 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2022-04-21 |
4 |
AS |
$144.15 |
$93,986 |
D/D |
(652) |
76,975 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2022-02-03 |
4 |
AS |
$136.14 |
$95,706 |
D/D |
(703) |
78,244 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2020-02-03 |
4 |
AS |
$108.51 |
$78,887 |
D/D |
(727) |
108,009 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2021-02-02 |
4 |
D |
$163.97 |
$119,370 |
D/D |
(728) |
109,544 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2022-02-02 |
4 |
AS |
$137.58 |
$101,672 |
D/D |
(739) |
78,947 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-02-02 |
4 |
AS |
$138.52 |
$108,461 |
D/D |
(783) |
96,853 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2022-04-20 |
4 |
AS |
$144.32 |
$113,579 |
D/D |
(787) |
77,627 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2020-06-16 |
4 |
AS |
$157.15 |
$131,692 |
D/D |
(838) |
111,770 |
0 |
% |
|
| SGEN |
Seagen Inc |
See Remarks |
• – – |
2019-09-03 |
4 |
AS |
$70.80 |
$65,277 |
D/D |
(922) |
106,146 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2024-05-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
4,583 |
0 |
- |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-08-29 |
4 |
AS |
$206.00 |
$209,296 |
D/D |
(1,016) |
115,797 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2020-04-21 |
4 |
D |
$139.92 |
$162,164 |
D/D |
(1,159) |
117,233 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2018-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,343 |
71,343 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2021-08-16 |
4 |
AS |
$154.55 |
$256,096 |
D/D |
(1,657) |
72,778 |
0 |
% |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,660 |
98,513 |
0 |
- |
|
| SGEN |
Seagen Inc |
President, R&D & CMO |
• – – |
2023-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,872 |
116,813 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
AS |
$114.07 |
$228,140 |
D/D |
(2,000) |
101,146 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Medical Officer |
• – – |
2020-06-17 |
4 |
AS |
$157.74 |
$343,523 |
D/D |
(2,162) |
109,608 |
0 |
% |
|
74 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
